(Q58234807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

Rob Nelissen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Anja Garritsen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

René van Schaik

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cees M Meeuwisse

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michael P van der Linden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ton A Rullmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cornelia F Allaart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Tom W Huizinga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

1265-1273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis a

22 January 2020

cites work

1 reference

Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?

21 January 2018

1 reference

Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers

21 January 2018

1 reference

In silico modeling and simulation of bone biology: a proposal

21 January 2018

1 reference

Systems biology for battling rheumatoid arthritis: application of the Entelos PhysioLab platform.

21 January 2018

1 reference

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

21 January 2018

1 reference

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

21 January 2018

1 reference

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis

21 January 2018

1 reference

Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts

21 January 2018

1 reference

Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production

21 January 2018

1 reference

CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function

21 January 2018

1 reference

Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells

21 January 2018

1 reference

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5

21 January 2018

1 reference

Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release

21 January 2018

1 reference

Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria

21 January 2018

1 reference

Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.30273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305530%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference